Oluwaseun Fatoba

St. Josef Hospital
Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pathogenic role of CD169+ macrophages in neuronal loss and motor decline in NMO mice.

Pathogenic role of CD169+ macrophages in neuronal loss and motor decline in NMO mice.

Journal: Experimental neurology

Published: March 21, 2025

Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington's Disease.

Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington's Disease.

Journal: International journal of molecular sciences

Published: January 27, 2025

Investigation of Inter- and Intra-Day Variability of Tear Fluid Regarding Flow Rate, Protein Concentration as well as Protein Composition.

Investigation of Inter- and Intra-Day Variability of Tear Fluid Regarding Flow Rate, Protein Concentration as well as Protein Composition.

Journal: Investigative ophthalmology & visual science

Published: October 10, 2023

Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases.

Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases.

Journal: Frontiers in cellular neuroscience

Published: March 07, 2023

Complement cascade functions during brain development and neurodegeneration.

Complement cascade functions during brain development and neurodegeneration.

Journal: The FEBS journal

Published: October 25, 2020

Microglia as therapeutic target in central nervous system disorders.

Microglia as therapeutic target in central nervous system disorders.

Journal: Journal of pharmacological sciences

Published: March 31, 2020

Immunotherapies in Huntington's disease and α-Synucleinopathies.

Immunotherapies in Huntington's disease and α-Synucleinopathies.

Journal: Frontiers in immunology

Published: December 04, 2019

Author Correction: Laquinimod treatment in the R6/2 mouse model.

Author Correction: Laquinimod treatment in the R6/2 mouse model.

Journal: Scientific reports

Published: March 16, 2019

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.

Journal: Experimental neurology

Published: October 31, 2017

Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.

Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.

Journal: Journal of neuroimmunology

Published: February 14, 2017

Laquinimod treatment in the R6/2 mouse model.

Laquinimod treatment in the R6/2 mouse model.

Journal: Scientific reports

Published: February 01, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026